The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
New research provides the first direct evidence that brain lesions causing secondary psychosis map to a common brain circuit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback